Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carvedilol.

× No keyword cloud information.

44 in total

Review 1. Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?

Authors: F Dunne; M J Kendall; U Martin
Journal: Drugs Date: 2001 Impact factor: 9.546

Review 2. Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.

Authors: William H Frishman; Mamata Alwarshetty
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

Review 3. Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors: Jonathan B Finkel; Gregary D Marhefka
Journal: Mayo Clin Proc Date: 2011-12 Impact factor: 7.616

Review 4. The role of Beta-blockers as first-line therapy in hypertension.

Authors: Alberto Ranieri De Caterina; Antonio Maria Leone
Journal: Curr Atheroscler Rep Date: 2011-04 Impact factor: 5.113

Review 5. Management of portal hypertension.

Authors: D N Samonakis; C K Triantos; U Thalheimer; D W Patch; A K Burroughs
Journal: Postgrad Med J Date: 2004-11 Impact factor: 2.401

6. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.

Authors: J Rhodes; R Margossian; B T Darras; S D Colan; K J Jenkins; T Geva; A J Powell
Journal: Pediatr Cardiol Date: 2007-09-21 Impact factor: 1.655

7. Blockade of adrenoreceptors inhibits the splenic response to stroke.

Authors: Craig T Ajmo; Lisa A Collier; Christopher C Leonardo; Aaron A Hall; Suzanne M Green; Tracy A Womble; Javier Cuevas; Alison E Willing; Keith R Pennypacker
Journal: Exp Neurol Date: 2009-04-14 Impact factor: 5.330

Review 8. Beta-blocker pharmacogenetics in heart failure.

Authors: Jaekyu Shin; Julie A Johnson
Journal: Heart Fail Rev Date: 2008-04-24 Impact factor: 4.214

9. Preparation and evaluation of self-nanoemulsifying tablets of carvedilol.

Authors: Enas A Mahmoud; Ehab R Bendas; Magdy I Mohamed
Journal: AAPS PharmSciTech Date: 2009-02-24 Impact factor: 3.246

Review 10. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.

Authors: William H Frishman; Linda S Henderson; Mary Ann Lukas
Journal: Vasc Health Risk Manag Date: 2008